GeneTex
United States (US)

Galectin 1 recombinant protein

Cat No. GTX65159

Application ELISA, Functional Assay, Apuri, Blocking
Reactivity Human
Species Human
APPLICATION

Application Note

Protein's bioactivity determined by its ability to chemoattract human blood monocytes. Chemotactic activity was observed at a concentration of 2.5 ug/ml with a peak response obtained at 250 ug/ml.

Calculated MW

14.5 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Buffer

20 mM Tris, pH 7.5.

Storage

Reconstitute in water to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers and stored at 4ºC for 1 week or –20ºfor future use.

Antigen Species

Human

Expression System

E. coli

Purification


Purity was assessed by SDS-PAGE (≥98%) and by HPLC.

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Galectin1, beta-galactoside- binding lectin L-14-I, SLac lectin1, Lectin galactosidebinding soluble1, betagalactoside binding lectin L14I, Lectin galactosidebinding soluble 1, Putative MAPK-activating protein PM12, LGALS1, L, S-Lac lectin 1, Galaptin, DKFZp686E23103, Putative MAPKactivating protein PM12, S Lac lectin 1, SLac lectin 1

Background

Galectin-1 belongs to growing family of evolutionary conserved animal lectins. Galectins consists of beta-galactoside binding lectins that contain homologous carbohydrate recognition domains (CRDs). Galectin-1 has the ability to induce apoptosis of activated T-cells and T-leukaemia cell lines. Other activities include cell differentiation and inhibition activity of CD45 protein phosphatase activity. Galectin also binds beta-galactoside as well as CD45, CD3 and CD4. Recombinant Human Galectin is a 14.5 kDa protein consisting of 134 amino acid residues.

Research Area

Package List Price ($)
$ 199